Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

CERS:US

5.4600 USD 0.0300 0.55%

As of 20:10:00 ET on 01/29/2015.

Company Profile for Cerus Corp (CERS)

Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.

Contact Information

Cerus Corp

2550 Stanwell Drive
Concord, CA 94520
United States
Phone: 1-925-288-6000
Fax: 1-925-288-6001

Key Executives for Cerus Corp (CERS)

William Mariner Greenman "Obi"President/CEOChrystal N MenardChief Legal Officer
Caspar HogeboomPres:Cerus EuropeLaurence M CorashSenior VP/Chief Medical Ofcr/Co-Founder
Carol M MooreSenior VP:Regulatory AffairsKevin D GreenVP:Finance/CFO
Lori L RollSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil